Sign Up | Log In | What is SocialPicks?

6 pts

Opinion on 3SBio Inc. (SSRX)
Chinese biotech concept, huge growth potential

Feb 14, 2007 08:10 PM GMT

Derek Chen

Return	Risk
+0.60%	HIGH

Analyst

Profile & Performance

Subscribe to author

This is a great opportunity to tap on China's burgeoning pharmaceutical industry. SSRX holds various patents that are crucial in its market segment. Also an aging demorgraphic also points to a fast greying population which leads a bigger demand for healthcare services in China. Although it is small right now, it is expanding very fast. I definitely see huge growth potential in it. Definitely a long term buy.

SSRX: This call was made on 02/14/07 @ $16.61

Rating:	$16.61 (02/14/07)
Gain/Loss:	-18.30% in 1015 days
Target:	$25.00 (+50.51%) in Six months
Allocation:	54.4% of portfolio

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.25%	381
2	Gerald Greene	18.14	+72.34%	210
3	stockmarketfunding.com	17.66	+25.65%	55
4	akiralegrand	13.47	+14.32%	61
5	anup2104	12.13	+76.91%	39

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
MA	MasterCard Inc
T	AT&T Inc
FNM	Fannie Mae
SBUX	Starbucks Corp
MO	Altria Group Inc
ETFC	E*Trade Financial Corp

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

CLDA		BioMed Research Reports: Clinical Data (NASDAQ: CLDA), Lpath (OTC: ... by Mike Havrilla
PARD		Biotech Stocks - Beware of The Covered Call Trap by Ivan Mutaftchiev
PBIO		Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Un... by Mike Havrilla
ISIS		ISIS - Last Tuesday's Drop Presents a Nice Buy Opportunity by Ivan Mutaftchiev
ABIO		BioMed News Bytes: Transcept, ProUroCare, SciClone, ABIO by Mike Havrilla

... more »

3SBio Inc. (SSRX)

SocialPicks Sentiment:

This Quarter's Sentiment:

All:

100.0%

Top:

100.0%

Get Daily Email Alerts

Subscribe to Derek Chen

Receive Free Ideas Daily for This Sector

Latest Picks by Derek Chen

Symbol	Return	Since
JASO	-38.01%	02/14/07
WFMI	-39.55%	02/07/07
EDU	+91.53%	02/07/07
HMIN	-21.85%	02/07/07
TSL	+22.95%	02/07/07

View All >

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

Opinion on 3SBio Inc. (SSRX) Chinese biotech concept, huge growth potential

Opinion on 3SBio Inc. (SSRX)
Chinese biotech concept, huge growth potential